🇵🇱 Poland · EU Public Tender
Dostawa produktów leczniczych: 1. Niwolumab + Relatlimab; 2. Tepotynib, nr PN-110/24/TM
🏛️ Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy · 📍 Warszawa
—
Estimated value
27 June 2024
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Deadline | 27 June 2024 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.